Study Analyzes Impact of Broad Claims in Myriad BRCA1 Patent, Suggests USPTO Errors

Researchers from Duke University analyzed a BRCA patent using bioinformatics and found that the USPTO may have erred in granting a particularly broad claim in the patent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.